Aceragen | Capital Social E Reservas



Equity Capital And Reserves Alterar Data
Abbott USD 49.06B 9.04B 2025-03
Alnylam Pharmaceuticals USD 115.43M 48.35M 2025-03
Amgen USD 6.21B 330M 2025-03
Biogen USD 16.98B 262.7M 2025-03
BioMarin Pharmaceutical USD 5.79B 135.47M 2025-03
Cipla INR 311.93B 27.38B 2025-03
Clal Biotechnology ILS 121.41M 4.62M 2023-12
Compugen USD 54.91M 5.57M 2024-12
CSL USD 20.55B 3.18B 2024-12
Dynavax Technologies USD 530.94M 65.86M 2025-03
Eli Lilly USD 15.85B 1.65B 2025-03
Gilead Sciences USD 19.33B 856M 2024-12
GlaxoSmithKline GBP 14.16B 486M 2025-03
Grifols EUR 5.88B 533.83M 2024-12
Merck USD 48.34B 2.02B 2025-03
Pfizer USD 90.34B 2.14B 2025-03
Roche Holding CHF 36.16B 3.28B 2024-12
Sarepta Therapeutics USD 1.14B 385.02M 2025-03
Ultragenyx Pharmaceutical USD 144.25M 111.05M 2025-03
X T L Biopharmaceuticals USD 5.44M 282K 2024-12



Aceragen Capital Social E Reservas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.